Problems With Recalled Philips Heart Monitoring Application Linked to Injuries, Deaths
Faulty software program designed to be used with Philips medical devices is at the center of a class I recall.
Faulty software program designed to be used with Philips medical devices is at the center of a class I recall.
The FDA recall is the latest in a string of problems with Philips breathing devices, which have resulted in thousands of lawsuits in recent years.
$25 million Philips CPAP settlement will provide medical monitoring for users of recalled machines, after Court found the deal “fair, reasonable and adequate.”
Both companies have accused each other of being responsible for problems with Philips CPAP machines, which have been linked to injuries and deaths.
Judge will hear evidence regarding a proposed Philips medical monitoring settlement, which provides funds to help detect future injuries among individuals who previously used recalled CPAP, BiPAP and ventilators.
The recalled OmniLab Advanced+ Ventilators may unexpectedly and intermittently reboot, putting users at risk of respiratory failure.
This is at least the third Philips BiPAP recall to impact these devices in recent years due to various problems, including risks of device failures and exposure to toxic chemicals
Recall shortly after Philips agreed to pay $1.1 billion to settle CPAP recall lawsuits filed over toxic sound abatement foam in other breathing machines
The agreement comes just days after a federal judge approved a similar settlement resolving Philips CPAP class action lawsuit claims.
Under a new schedule issued last week, it is likely that Philips CPAP injury lawsuit bellwether trials will not begin until late 2025, at the earliest.